Literature DB >> 8078420

The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin.

I Morrissey1, J T Smith.   

Abstract

There is an inoculum size effect associated with the bactericidal potency of 4-quinolones. This phenomenon has previously been attributed to anaerobic conditions at high initial inoculum sizes. The level of anaerobicity present with Escherichia coli and Staphylococcus aureus at varying initial inoculum size was analysed by measuring dissolved oxygen concentrations and redox potentials. Such measurements confirmed that conditions at high initial inoculum sizes are more anaerobic than conditions at low initial inoculum sizes. The precise concentration of oxygen at which 4-quinolones are no longer able to kill bacteria could not be deduced by either method. The results suggest that extremely low oxygen levels are needed to antagonise 4-quinolone kill. This explains why very stringent conditions are required to render media anaerobic enough to prevent the bactericidal activity of 4-quinolones against bacteria at low initial inoculum sizes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078420

Source DB:  PubMed          Journal:  Microbios        ISSN: 0026-2633


  11 in total

1.  Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions.

Authors:  David H Wright; Brent W Gunderson; Laurie B Hovde; Gigi H Ross; Khalid H Ibrahim; John C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 2.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

3.  Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei.

Authors:  Mohamad A Hamad; Chad R Austin; Amanda L Stewart; Mike Higgins; Andrés Vázquez-Torres; Martin I Voskuil
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

4.  Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.

Authors:  Jeffrey J Campion; Patrick J McNamara; Martin E Evans
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Plasmid DNA supercoiling and survival in long-term cultures of Escherichia coli: role of NaCl.

Authors:  Annie Conter
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

6.  Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.

Authors:  Kumiko Kurabayashi; Koichi Tanimoto; Shinobu Fueki; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

7.  Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli.

Authors:  Daniel J Dwyer; Michael A Kohanski; Boris Hayete; James J Collins
Journal:  Mol Syst Biol       Date:  2007-03-13       Impact factor: 11.429

8.  Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic Escherichia coli (EHEC) by Elevating the Expression of glpT and uhpT under Anaerobic Conditions.

Authors:  Kumiko Kurabayashi; Koichi Tanimoto; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  Front Microbiol       Date:  2017-03-16       Impact factor: 5.640

9.  Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter.

Authors:  Hidetada Hirakawa; Kumiko Kurabayashi; Koichi Tanimoto; Haruyoshi Tomita
Journal:  Front Microbiol       Date:  2018-08-21       Impact factor: 5.640

10.  RegAB Homolog of Burkholderia pseudomallei is the Master Regulator of Redox Control and involved in Virulence.

Authors:  Julia Phenn; Jan Pané-Farré; Nikolai Meukow; Annelie Klein; Anne Troitzsch; Patrick Tan; Stephan Fuchs; Gabriel E Wagner; Sabine Lichtenegger; Ivo Steinmetz; Christian Kohler
Journal:  PLoS Pathog       Date:  2021-05-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.